Top Markets
Coin of the day
Eurobio Scientific Société anonyme Eurobio Scientific Société anonyme

Eurobio Scientific Société anonyme

ALERS
Classifica tra le azioni #10866
Eurobio Scientific Société anonyme designs, develops, and commercializes... Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Prezzo delle azioni
$25.15
Capitalizzazione di mercato
$253.18M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-12.08%
Paese
FR
Scambia Eurobio Scientific Société anonyme (ALERS)

Categoria

Ricavi di Eurobio Scientific Société anonyme (ALERS)
Ricavi nel Dec 2025 TTM: $197.93M
Secondo gli ultimi rapporti finanziari di Eurobio Scientific Société anonyme, i ricavi attuali dell'azienda (TTM) sono pari a $197.93M. Nel 2023, l'azienda ha registrato ricavi di $144.42M una diminuzione rispetto a i ricavi dell'anno 2022, che erano pari a $163.70M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Eurobio Scientific Société anonyme da 2007 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $197.93M 22.76%
2024 $161.23M 11.64%
2023 $144.42M -11.77%
2022 $163.70M -22.07%
2021 $210.04M -8.68%
2020 $230.00M 244.68%
2019 $66.73M 13.70%
2018 $58.69M 14.33%
2017 $51.33M 75.33%
2016 $29.28M -9.46%
2015 $32.34M -13.91%
2014 $37.56M -12.50%
2013 $42.93M 504.10%
2012 $7.11M 9.96%
2011 $6.46M -42.58%
2010 $11.25M 60.45%
2009 $7.01M 19.30%
2008 $5.88M -25.30%
2007 $7.87M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$45.13B 22,702.70%
US
$25.27B 12,666.97%
US
$36.37B 18,275.31%
IE
$20.62B 10,315.16%
US
$6.30B 3,084.67%
US